“…This tumour destructive treatment is based on the work of Dr John Holt, who claimed that glucose-blocking agents used with 434MHz radio waves (microwaves) were an effective cancer therapy in some patients."

Dr John Holt was a consultant radiotherapist at the Royal Perth Hospital in 1961. He was also medical director of the Institute of Radiotherapy and Oncology of Western Australia. He has had more than 30 papers published, including a report on the first bone marrow transplantation following whole-body radiation to take place in the southern hemisphere . John Holt was the first person to treat Hodgkin's disease using extended mantle fields. This technique, first used in 1962, was taken up by Stanford University in 1968 without acknowledgement.
In 1973 he proposed the theory that cancer cells are electrically different to normal cells and demonstrated that ultra-high-frequency currents at 434 MHz interact with cancer cells by non-thermal resonance, thereby creating a significant increase in the cancers sensitivity to radiation.  John also proposed that cancer was a disease of defective glucose metabolism, and a paper on this appeared in medical hypotheses in 1983. John suggested that glucose with oxygen controls normal cell division. Cancer is at fault in this control which makes it cancerous. There are 16 case histories described in his patent which can be viewed at
http://v3.espacenet.com/publicationDetails/originalDocument?CC=EP&NR=0705603&KC=&FT=E
If the cancer cell's uptake of glucose from the blood  can be blocked before applying UHF radiation the cancer cell will die. This is selective killing because it only acts on the glucose to lactic acid system.
Photographs and radiographs of 19 patients supplied to me by Dr. Holt as a personal communication are shown below.

There are too many patients of Dr Holt  like David Bonnin, now a director of the Radiowave Research Institute who is in year 6 of remission from Waldenstroms Macroglobulineamia to abandon this research.

Further Dr Holt has demonstrated success with mesothelioma which is rare.

Radiowave therapy  is free of serious side effects, safe and non-toxic.

"Radio-wave Therapy & Glucose Blocking Agents may be applied in many cases of cancer where surgery, chemotherapy and X-ray radiation are contra-indicated….Treatment with Radio-wave Therapy & Glucose Blocking Agents may work in situations where surgery would not be feasible.”

These patients did not have other anti-cancer therapies at the time when they had Holt Radiowave therapy without radiation therapy. Therefore the specific effect of the radiowave therapy can be evaluated.

The NHMRC were looking for randomised double blind studies and would not accept a lot of Dr Holt's research.  It is obvious from this small group of patients that there is scientific data and evidence of benefit and more research needs to be done.

Surgery is of no use in mesothelioma so the case with bilateral mesothelioma demonstrates that Holt Radiowave Therapy does work in situations where surgery would not be feasible.

1. Cancer en cuirasse where surgery, chemotherapy and radiation had failed. First treated 12 January 1976 with almost complete resolution on 20 June 1976.

4.  A sideways x-ray of a male patient age 56 with a secondary in his chest from a bladder cancer. This has been proven by needle biopsy. His bladder was treated three years before the stage three primary cancer in the bladder and he has remained free of disease in the bladder since then.
X-ray taken two months after the previous X to show the effect of 15 doses of glucose blocking agents and microwaves in clearing the secondary disease from the lung.

5. Secondary malignant deposits from cancer of the kidney which had previously been removed by surgery. Three courses of treatment with cytotoxic chemotherapy had been ineffective. Following 15 days of treatment using intravenous Cystine and oxidised glutathione followed by radio waves on each occasion this x-ray two months later shows complete resolution of the secondaries. She remains well three years later.

7. Pancreatic cancer blocking the common bile duct: This patient was given a course of 12 treatments using glucose blocking agents +434 MHz radio waves.  No x-ray therapy was used. Fifth of September 1974 a decompression of his obstruction by external drain: injected dye only perfuses the liver because the cancer obstructs the common bile duct from the liver and pancreas to the duodenum. 17th of October 1974 after the treatment injected Dye enters the duodenal normally! The tea tube drain was removed and there was no sign of cancer in 2004.

Recurrent Medulloblastoma  age 9 when treated. Proven medulloblastoma of the posterior cranial fossa partly excised by surgery followed by a radical course of radiotherapy to the skull. Preoperative CT scan taken 28th of July 2000. Large residual tumour actively regrowing causing pain, nausea, weakness of spinal muscles, difficultly in standing and balancing. MRI taken 21st of May 2001 shows a large soft tissue mass still present at the site of the original tumour. A 15 day course of anaerobic glycolytic blocking agents and UHF given between 13th and 31st of August 2001 which caused complete resolution of all her major symptoms. Second course of treatment 2nd of January to 25 January 2002. MRI dated 2nd September 2002 shows no abnormal signals in the posterior fossa to suggest recurrence. Site of the previous lesions now cavity filled with cerebro spinal fluid. No evidence of active malignancy, alive and well in May 2006.

9. Cerebral computerised tomographic scan of a  41-year-old patient dated eighth of April 1997. A Short history of one month of drowsiness and they are followed by memory loss, confusion, unsteady gait and generalised weakness. The dense black areas in the scan represent the ventricles or the cavities in the brain containing the cerebrospinal fluid. The tumour can be seen occupying the ventricles.
The ventricles, or cavities in the brain,  are seen  well in pictures two, three, four and 5.
compared with the illustration above this computerised scanning was performed on 8 May 1997.Treatment consisted of glucose blocking agents followed by radio-wave therapy to  the skull on the 28th 29th and 30th April and the first second fifth sixth and seventh of May 1997, eight treatments only.
The radiologist concluded that there has been 15 and 14 year survival cancer free has been achieved when reviewed in 2004. A dramatic response to therapy and the majority of the malignancy has disappeared. The biopsy in April showed this to be a grade 3 to 4 Glioblastoma multiforme.
This is an extremely malignant brain tumour. The records of the Western Australian Cancer Registry show that no patient with malignant glial brain cancer has survived, apparently cured, after any form of surgery, radiotherapy and /all cytotoxic treatment.
Several similar complete disappearances of inoperable and otherwise untreatable brain cancers have had similar responses from this method.
When reviewed in 2004 there was one patient with a four-year remission, one patient with a five-year remission, and one patient with a seven year remission.

10. Malignant Pineoblastoma: the patient was diagnosed with a needle biopsy and was treated with 5400 raids over 30 treatments. There was a failure to control intracranial pressure on the patient was referred for anaerobic glycolytic blocking agents and radio waves.  After a 15 day course of therapy from 12 July to 30 July 1999 there was complete relief of all symptoms and the patient was alive and well when reviewed in 2004.

11. A chest x-ray of a female with primary adenocarcinoma in the upper right lung region with secondaries in the central mediastinal lymph nodes. Both sites were proven fine-needle biopsy and x-ray on 29 March 1993. X-ray of patient on 1 July after 11 treatments of glucose blocking agents with UHF. There was no recurrence three years later.

12. There was a collapse of the right upper lung on 16 July 1982 due to blockage of the right main bronchus from squamous cell carcinoma. Left photograph before treatment, right photograph two months later, 24th of September 1982. This is a moderately common type of lung cancer and does not respond to conventional x-ray therapy safe dosage levels. No recurrence when last seen five years late17.

The only patient with bilateral mesothelioma  disease of the pleura.
X-ray taken on 13 May 1986.
Treatment in June 1986.
Review x-ray November 1087 shows clearance of the mesothelioma.